Fig. 1.

Structure of NAX 409-9. The peptide was derived from the native galanin fragment, gal(1–16), with subsequent C-terminal dPEG modification. The chemical structure, synthesis, galanin receptor binding, and pharmacologic screening of this compound have been previously described (Zhang et al., 2013).